Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil (2019)
- Authors:
- USP affiliated authors: SUEMOTO, CLAUDIA KIMIE - FM ; BENSEÑOR, ISABELA JUDITH MARTINS - FM ; LOTUFO, PAULO ANDRADE - FM
- Unidade: FM
- DOI: 10.1016/j.psyneuen.2019.01.003
- Subjects: BIOMARCADORES; INFLAMAÇÃO; TRANSTORNOS COGNITIVOS; ESTUDOS LONGITUDINAIS; DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; RESISTÊNCIA À INSULINA
- Agências de fomento:
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Financiado pelo MCTI
- Brazilian Ministry of Health (Science and Technology Department)
- National Postdoctoral Program (PNPD-CAPES), Brazil
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Processo FAPESP: 2009/15041-9
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Psychoneuroendocrinology
- ISSN: 0306-4530
- Volume/Número/Paginação/Ano: v. 103, p. 61-66, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CEZARETTO, Adriana et al. Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil. Psychoneuroendocrinology, v. 103, p. 61-66, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.psyneuen.2019.01.003. Acesso em: 23 abr. 2024. -
APA
Cezaretto, A., Almeida-pititto, B. de, Alencar, G. P., Suemoto, C. K., Benseñor, I. J. M., Lotufo, P. A., et al. (2019). Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil. Psychoneuroendocrinology, 103, 61-66. doi:10.1016/j.psyneuen.2019.01.003 -
NLM
Cezaretto A, Almeida-pititto B de, Alencar GP, Suemoto CK, Benseñor IJM, Lotufo PA, Ferreira SRG, Aquino EML, Mota ELA, Barreto SM. Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil [Internet]. Psychoneuroendocrinology. 2019 ; 103 61-66.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.psyneuen.2019.01.003 -
Vancouver
Cezaretto A, Almeida-pititto B de, Alencar GP, Suemoto CK, Benseñor IJM, Lotufo PA, Ferreira SRG, Aquino EML, Mota ELA, Barreto SM. Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil [Internet]. Psychoneuroendocrinology. 2019 ; 103 61-66.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.psyneuen.2019.01.003 - Association of Sarcopenia with performance on multiple cognitive domains: results From the ELSA-Brasil Study
- Serum uric acid is associated with better executive function in men but not in women: Baseline assessment of the ELSA-Brasil study
- Thyroid function and sarcopenia: results from the ELSA-Brasil study
- Measurement Invariance of Neuropsychological Tests Across Different Sociodemographic Backgrounds in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
- Association of adiponectin with cognitive function precedes overt diabetes in the Brazilian Longitudinal Study of Adult Health: ELSA
- Glaucoma, but not cataracts, predicts lower verbal fluency performance: 3.8-year follow-up from the ELSA-Brasil study
- Depression is associated with sarcopenia due to low muscle strength: results from the ELSA-Brasil Study
- Dense low-density and remnant lipoprotein cholesterol are associated with adiposity: the ELSA-Brasil study
- Association between cognitive performance and self-reported glaucoma in middle-aged and older adults: a cross-sectional analysis of ELSA-Brasil
- Orthostatic hypotension and cognitive function: cross-sectional results from the ELSA-Brasil study
Informações sobre o DOI: 10.1016/j.psyneuen.2019.01.003 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
